We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 08, 2019

Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Node-Positive Cervical Cancer

JAMA Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer
JAMA Oncol 2019 Nov 27;[EPub Ahead of Print], JS Mayadev, D Enserro, YG Lin, DM Da Silva, HA Lankes, C Aghajanian, S Ghamande, KN Moore, VA Kennedy, PM Fracasso, RJ Schilder

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading